38 results on '"Pavlíček, Petr"'
Search Results
2. Various phenotypes of disease associated with mutated DGKE gene
3. Secondary flow of second kind in a short channel observed by PIV
4. Severe Acute Kidney Injury in Children as a Rare Complication of Paroxysmal Cold Hemoglobinuria
5. P1294: REAL-WORLD OUTCOMES OF 2149 NEWLY DIAGNOSED TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS
6. An Analysis of the Bi-modal Size Distribution of the Coarse Droplets in a Steam Turbine
7. P32 - INFANT EXTRAMEDULLARY KMT2A REARRANGED T/MYELOID ACUTE LEUKEMIA MIMICKING LANGERHANS CELL HISTIOCYTOSIS
8. Efficacy and Safety of Oral Ixazomib (Ixa), Intravenous (IV) Daratumumab (Dara), and IV/Oral Dexamethasone (Dex; IDd) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) and 1-3 Prior Therapies: Results of the Final Analysis of a Phase 2 Study
9. 10 years of experience with thalidomide in multiple myeloma patients: Report of the Czech Myeloma Group
10. Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data
11. Bilateral Amyloidosis of Three Eyelids. A Case Report
12. P-210: Oral ixazomib (Ixa), IV daratumumab (Dara), and dexamethasone (dex; IDd) in relapsed/refractory multiple myeloma (RRMM) patients (pts) with 1–3 prior therapies: phase 2 study interim analysis (IA)
13. OAB-046: COVID-19 infection in multiple myeloma patients – retrospective analysis of 371 Czech patients
14. Multicentered patient-based evidence of the role of free light chain ratio normalization in multiple myeloma disease relapse
15. Bortezomib‐based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data
16. P-159 Lenalidomide maintenance in R2-ISS stratified multiple myeloma patients - real world evidence
17. Identification of patients with smouldering multiple myeloma at ultra‐high risk of progression using serum parameters: the Czech Myeloma Group model
18. The Reynolds number effect on dynamics of the wake behind a circular cylinder
19. P-177: Outcomes in risk-stratified patients with smoldering multiple myeloma: a retrospective analysis of real-world data from the Czech Registry of Monoclonal Gammopathies
20. An Experimental Study of the Coarse Droplets Formation.
21. Experimental equipment for an electrical resistance tomography of a gas lift flow
22. Local Reynolds number
23. Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in Czech Republic
24. Comfort parameters – Ventilation of a subway wagon
25. Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies
26. Selected Genetic Polymorphisms Associated with Hypoxia and Multidrug Resistance in Monoclonal Gammopathies Patients
27. Experimental equipment for an electrical resistance tomography of a gas lift flow
28. Creation of humour in plays Antonin Prochazka 'Pilsen Moliere'
29. Overall Survival Benefit of Ixazomib, Lenalidomide and Dexamethasone (IRD) over Lenalidomide and Dexamethasone (RD) in RRMM Patients Treated in Routine Clinical Practice: Results from the Czech Registry of Monoclonal Gammopathies (RMG)
30. Registry of Monoclonal Gammopathies (RMG) - the monitored real-world database of the Czech Myeloma Group
31. Real-world comparison of Ixazomib, lenalidomide and dexamethasone vs lenalidomide and dexamethasone in relapsed and refractory multiple myeloma
32. Urine immunofixation is not necessary for CR definition in myeloma patients with complete M protein molecule
33. Management of urban forests
34. Multicentered patient‐based evidence of the role of free light chain ratio normalization in multiple myeloma disease relapse
35. Multiple Myeloma R-ISS Prognostic Stratification System in Real Life Population
36. Bortezomib (Velcade) in the Treatment of Relapsed or Refractory Multiple Myeloma: Analysis of Safety and Efficacy of Bortezomib From Registry of Monoclonal Gammopathy of Czech Myeloma Group
37. The Reduced Intensity Cvd Regimen: A Good Option with Well Balanced Efficacy/Toxicity Ratio for Elderly Patients with Poor Status Performance
38. Consolidation Therapy Based on Conventional Chemotherapy and Corticoids Do Not Provide Therapeutic Advantage for Newly Diagnosed Patients after Autologous Transplantation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.